Track topics on Twitter Track topics that are important to you
BioPortfolio has launched a number of Facebook pages to allow our visitors to keep track with latest news, published paper and clinical trials by lead biotechnology and healthcare topics:- &nbs...
A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...
Siemens Healthcare is the second largest medical devices company in the world (based on annual sales), with sales of $17.4 billion. Specializing in the imaging, IT, diagnostics and workflow soluti...
Clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will norma...
An antibody, also known as an immunoglobulin, is a large Y-shaped protein used by the immune system to identify and neutralize foreign objects such as bacteria and viruses. The antibody recognizes a...
As reconstructive pelvic surgeons sought to reduce anatomical and symptomatic recurrence of transvaginal prolapse, the concept of incorporating an augmenting material was adopted. With this idea, simi...
Kentucky has filed a lawsuit against Johnson & Johnson’s medical device unit, Ethicon, alleging it concealed and purposely misrepresented the risks involved in its surgical transvaginal mesh pr...
[Articles] Mesh, graft, or standard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT)
Augmentation of a vaginal repair with mesh or graft material did not improve women's outcomes in terms of effectiveness, quality of life, adverse effects, or any other outcome in the short term, but m...
The national law firm of Baron & Budd is now accepting lawsuits on behalf of patients who suffered health problems after being implanted with a hernia mesh as part of a surgical procedure.
Among patients undergoing incisional hernia repair, the use of mesh to reinforce the repair was associated with a lower risk of hernia recurrence over 5 years compared with when mesh was not used, alt...
A judge speaks frankly about what he plans to do if lawyers keep pressing questionable vaginal-mesh cases.
A synthetic mesh commonly used to treat a form of urinary incontinence as well as the weakening of the female pelvis's walls can lead to complications that increase in frequency with the amount of mes...
New data on the use of mesh in patients undergoing hernia repair prompt nuanced discussion about the benefit and risk calculation, with emphasis on the need for long-term postsurgical follow-up. Med...
To identify litigation predictors among women with complications of transvaginal mesh.
To measure the proportion of women with transvaginal prolapse mesh complications and their association with surgeon volume.
To update clinical practice guidelines on graft and mesh use in transvaginal pelvic organ prolapse repair based on systematic review.
Synthetic mesh utilized to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) can often result in postoperative complications. The objectives of this study were to determine: 1) t...
The purpose of this study was to explore the association between mesh location and de novo stress urinary incontinence (SUI) after transvaginal mesh procedures.